These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7531752)

  • 21. Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients.
    Cleland A; Watson HG; Robertson P; Ludlam CA; Brown AJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):6-18. PubMed ID: 8624762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which are significant in nucleoside analog resistance.
    Lacey SF; Larder BA
    J Virol; 1994 May; 68(5):3421-4. PubMed ID: 7512165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
    Miranda LR; Götte M; Liang F; Kuritzkes DR
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different properties of wild type and drug-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase in vitro.
    Ijichi K; Fujiwara M; Shigeta S; Konno K; Yokota T; Baba M
    Microbiol Immunol; 1996; 40(5):353-8. PubMed ID: 8805099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
    Lukashov VV; Huismans R; Jebbink MF; Danner SA; de Boer RJ; Goudsmit J
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):807-18. PubMed ID: 11429122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies.
    Sato H; Tomita Y; Shibamura K; Shiino T; Miyakuni T; Takebe Y
    J Virol; 2000 Jun; 74(11):5357-62. PubMed ID: 10799614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
    Larder BA; Kemp SD
    Science; 1989 Dec; 246(4934):1155-8. PubMed ID: 2479983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of HIV isolates arising after prolonged zidovudine therapy.
    Mayers DL; McCutchan FE; Sanders-Buell EE; Merritt LI; Dilworth S; Fowler AK; Marks CA; Ruiz NM; Richman DD; Roberts CR
    J Acquir Immune Defic Syndr (1988); 1992; 5(8):749-59. PubMed ID: 1381438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.
    Bruisten SM; Reiss P; Loeliger AE; van Swieten P; Schuurman R; Boucher CA; Weverling GJ; Huisman JG
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1053-8. PubMed ID: 9718120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 reverse transcriptase codon 215 mutation and clinical outcome in children treated with zidovudine.
    Principi N; Marchisio P; De Pasquale MP; Massironi E; Tornaghi R; Vago T
    AIDS Res Hum Retroviruses; 1994 Jun; 10(6):721-6. PubMed ID: 7521192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group.
    Mayers D; Bethel J; Wainberg MA; Weislow O; Schnittman S
    J Infect Dis; 1998 Jun; 177(6):1730-3. PubMed ID: 9607859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine.
    Kaye S; Loveday C; Tedder RS
    J Med Virol; 1992 Aug; 37(4):241-6. PubMed ID: 1383414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and genetical analysis of AZT-resistant HIV-mutants.
    Biesert L; Zimmermann F; Schröder B; Matthes E; Suhartono H; Dietrich U; Rübsamen-Waigmann H
    Behring Inst Mitt; 1991 Jul; (89):74-80. PubMed ID: 1930105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.
    Kharytonchyk S; King SR; Ndongmo CB; Stilger KL; An W; Telesnitsky A
    J Mol Biol; 2016 Jun; 428(11):2275-2288. PubMed ID: 27075671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients.
    Wildemann B; Haas J; Ehrhart K; Wagner H; Lynen N; Storch-Hagenlocher B
    Neurology; 1993 Dec; 43(12):2659-63. PubMed ID: 7504798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.
    Larder BA; Kemp SD; Harrigan PR
    Science; 1995 Aug; 269(5224):696-9. PubMed ID: 7542804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of HIV-1 proviral DNA and analysis of genomic diversity by polymerase chain reaction and temperature gradient gel electrophoresis.
    Wieland U; Suhr H; Salzberger B; Eggers HJ; Braun RW; Kühn JE
    J Virol Methods; 1996 Apr; 57(2):127-39. PubMed ID: 8801225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.
    Kellam P; Boucher CA; Larder BA
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1934-8. PubMed ID: 1371886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase.
    Balzarini J; Karlsson A; Pérez-Pérez MJ; Vrang L; Walbers J; Zhang H; Oberg B; Vandamme AM; Camarasa MJ; De Clercq E
    Virology; 1993 Jan; 192(1):246-53. PubMed ID: 7685964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological testing versus sequence analysis for determination of drug resistance of human immunodeficiency virus.
    Wichers M; Kaiser R; Rockstroh J; Matz B; Schneweis KE
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):457-65. PubMed ID: 8837404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.